APA (7th ed.) Citation

Schilder, A. G. M., Wolpert, S., Saeed, S., Middelink, L. M., Edge, A. S. B., Blackshaw, H., . . . Bibas, A. G. (2024). A phase I/IIa safety and efficacy trial of intratympanic gamma-secretase inhibitor as a regenerative drug treatment for sensorineural hearing loss. Nature communications, 15(1), 1896-9. https://doi.org/10.1038/s41467-024-45784-0

Chicago Style (17th ed.) Citation

Schilder, Anne G. M., Stephan Wolpert, Shakeel Saeed, Leonie M. Middelink, Albert S. B. Edge, Helen Blackshaw, Kostas Pastiadis, and Athanasios G. Bibas. "A Phase I/IIa Safety and Efficacy Trial of Intratympanic Gamma-secretase Inhibitor as a Regenerative Drug Treatment for Sensorineural Hearing Loss." Nature Communications 15, no. 1 (2024): 1896-9. https://doi.org/10.1038/s41467-024-45784-0.

MLA (9th ed.) Citation

Schilder, Anne G. M., et al. "A Phase I/IIa Safety and Efficacy Trial of Intratympanic Gamma-secretase Inhibitor as a Regenerative Drug Treatment for Sensorineural Hearing Loss." Nature Communications, vol. 15, no. 1, 2024, pp. 1896-9, https://doi.org/10.1038/s41467-024-45784-0.